Latest Innovation News

Locate Technologies moves closer to shifting its listing from the ASX to the New Zealand Exchange, completing a NZ$1 million share offer as part of its capital restructure.

Zelira Therapeutics has received a $1.07 million cash refund under Australia’s R&D Tax Incentive Scheme, reinforcing its funding for ongoing clinical trials and product development. The company has also repaid a prior loan advanced against this claim, positioning it for continued growth in cannabinoid-based medicines.

Macquarie Technology Group unveiled ambitious plans to expand its AI-optimised data centre footprint, supported by a $450 million debt facility and strong growth across its cloud, government cybersecurity, and telecom divisions.

ABx Group has successfully raised over $6 million through a share placement to fund rapid development of its Deep Leads rare earth project and ALCORE pilot plant in Tasmania.

New Frontier Minerals has raised $2.25 million to fast-track development of its Harts Range rare earths project, leveraging a promising new processing technology from Metallium Ltd. The capital injection supports an imminent drilling campaign and advances a mining lease application in Queensland.

Mesoblast Limited forecasts a significant jump in quarterly revenue, driven by strong sales of its FDA-approved cell therapy Ryoncil. The company’s latest update highlights robust growth and ongoing expansion in inflammatory disease treatments.

Legacy Minerals reports significant progress across its exploration portfolio, with Earth AI completing a major earn-in at Fontenoy and Rio Tinto gearing up for a deep geophysical survey at Thomson. Ongoing drilling and partner commitments highlight the company’s potential for new discoveries.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Narryer Metals has outlined a substantial Exploration Target for its Rocky Gully Project in Western Australia, highlighting promising grades of scandium, rare earth elements, gallium, and potential titanium co-products. The company is gearing up for a new drilling campaign aimed at defining a maiden resource.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.

Centuria Capital Group has expanded its agriculture portfolio by acquiring Australia’s largest hydroponic glasshouse facility in South Australia for $168 million, boosting its agriculture assets under management by 25%.

Atturra Limited reported a robust 24% increase in both revenue and underlying EBITDA for FY25, propelled by its cloud platform, AI innovations, and defence sector contracts. The company forecasts continued momentum into FY26 with ambitious growth targets.